Health services use and health care costs of obese and nonobese individuals

Archives of Internal Medicine

Volumn 164, Issue 19, 2004, Pages 2135-2140

  Raebel, Marsha A ^a,c,f   Malone, Daniel C ^d   Conner, Douglas A ^a   Xu, Stanley ^a   Porter, Julie A ^b,c,e   Lanty, Frances A ^b,c  

^a Clinical Research Unit   (United States)

^b School of Pharmacy ^*  (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Aventis Pharmaceuticals   (United States)

^f CLINICAL RESEARCH UNIT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIDIABETIC AGENT; ANTITHYROID AGENT; ANTIULCER AGENT; CARDIOVASCULAR AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHRONIC DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; COST OF ILLNESS; COST UTILITY ANALYSIS; DRUG COST; FEMALE; HEALTH CARE FINANCING; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORBID OBESITY; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX RATIO;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 6944222787     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.19.2135     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Update: prevalence of overweight among children, adolescents, and adults - United States, 1988-1994. MMWR Morb Mortal Wkly Rep. 1997;46:198-202.
2. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US Adults, 1999-2000. JAMA. 2002;288:1723-1727.
3. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-660.
4. National Institutes of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Obes Res. 1998;6(suppl 2):51S-209S.
5. Peeters A, Barendregt JJ, Willekens F, et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24-32.
6. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA. 2003;289:187-193.
7. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res. 1998;6:97-106.
8. Wolf AM, Colditz GA. The cost of obesity: the US perspective. Pharmacoeconomics. 1994;5(suppl 1):34-37.
9. Porter JA, Raebel MA, Lanty FA, et al. The long-term outcomes of sibutramine effectiveness on weight (LOSE Weight) study in a managed care organization: six month clinical outcomes in a naturalistic clinical setting: American Heart Association. Scientific Sessions 2001, Anaheim, California, November 11, 2001 [abstract]. Circulation. 2001;104:11793. Abstract 3727.
10. Gay EC, Conner DA, Porter JA, et al. The long-term outcomes of sibutramine effectiveness on weight (LOSE Weight) study in a managed care organization: six month psychosocial outcomes in a naturalistic clinical setting Obes Res. 2001; 9(suppl 3):187S [abstract].
11. Lanty FA, Vogel EA, Malone DC, et al. Demographic and medication use of the Long-term Outcomes and Sibutramine Effectiveness for Weight (LOSE Weight) Study in a managed care organization [abstract]. Pharmacotherapy. 2000;20:1239. Abstract 55.
12. Porter JA, Raebel MA, Conner DA, et al. The long-term outcomes of sibutramine effectiveness on weight (LOSE Weight) study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization. Am J Manag Care. 2004;10:369-376.
13. Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weight. Med Care. 1995;33:783-795.
14. Harville DA. Maximum likelihood approaches to variance component estimation and to related problems. J Am Stat Assoc. 1977;72:320-338.
15. Laird N, Ware JH. Random effects models for longitudinal data. Biometrics. 1982;38:963-974.
16. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995;51:228-235.
17. Cox DR. The Analysis of Binary Data. London, England: Methuen; 1970.
18. Cox DR, Hinkley DV. Theoretical Statistics. London, England: Chapman Hall; 1974.
19. Breslow NE, Day NE. Statistical Methods in Cancer Research, Vol 1: The Analysis of Case-control Studies. Lyon, France: International Agency on Cancer, 1980.
20. Berk KN, Lachenbruch PA. Repeated measures with zeros. Stat Methods Med Res. 2002;11:303-316.
21. Thompson D, Brown JB, Nichols GA, et al. Body mass index and future healthcare costs: a retrospective cohort study. Obes Res. 2001;9:210-218.
22. Narbro K, Agren G, Jonsson E, et al. Pharmaceutical costs in obese individuals: comparison with a randomly selected population sample and long-term changes after conventional and surgical treatment: the SOS intervention study. Arch Intern Med. 2002;162:2061-2069.
23. Quesenberry CP, Caan B, Jacobson A. Obesity, health services use, and health care costs among members of a health maintenance organization. Arch Intern Med. 1998;158:466-472.
24. Allison DB, Zannolli R, Narayan KMV. The direct health care costs of obesity in the United States. Am J Public Health. 1999;89:1194-1199.
25. Oster G, Edelsberg J, O'Sullivan AK, et al. The clinical and economic burden of obesity in a managed care setting. Am J Manag Care. 2000;6:681-689.
26. Thompson D, Edelsberg J, Colditz GA, et al. Lifetime health and economic consequences of obesity. Arch Intern Med. 1999;159:2177-2183.
27. Oster G, Thompson D, Edelsberg J, et al. Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health. 1999;89:1536-1542.
28. Agren G, Narbro K, Naslund I, et al. Long-term effects of weight loss on pharmaceutical costs I obese subjects: a report from the SOS intervention study. Int J Obes Relat Metab Disord. 2002;26:184-192.
29. Burton WN, Chen CY, Schultz AB, et al. The economic costs associated with body mass index in a workplace. J Occup Environ Med. 1998;40:786-792.
30. Sturm R. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood). 2002;21:245-253.